Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125788472 | 12578847 | 2 | F | 20160719 | 20160721 | 20160729 | PER | US-PFIZER INC-2016334915 | PFIZER | 54.00 | YR | F | Y | 0.00000 | 20160729 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125788472 | 12578847 | 1 | PS | FENTANYL CITRATE. | FENTANYL CITRATE | 1 | UNK | U | 19115 | ||||||||||
| 125788472 | 12578847 | 2 | SS | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | UNK | U | 0 | ||||||||||
| 125788472 | 12578847 | 3 | SS | CEFTIN | CEFUROXIME AXETIL | 1 | UNK | U | 0 | ||||||||||
| 125788472 | 12578847 | 4 | SS | BIAXIN | CLARITHROMYCIN | 1 | UNK | U | 0 | ||||||||||
| 125788472 | 12578847 | 5 | SS | CEFZIL | CEFPROZIL | 1 | UNK | U | 0 | ||||||||||
| 125788472 | 12578847 | 6 | SS | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | UNK | U | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125788472 | 12578847 | Drug hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |